NICE recommends Novartis’ wet AMD drug Beovu by Lucy Parsons | Dec 16, 2020 | News | 0 Final appraisal determination recommends anti-VEGF treatment for NHS use Read More
SMC accepts 14 new medicines for use by NHS Scotland by Selina McKee | Sep 8, 2020 | News | 0 The decisions bring a raft of new treatment options for conditions including epilepsy, depression and cancer Read More
Beovu bags EU approval in wet AMD by Anna Smith | Feb 18, 2020 | News | 0 The drug is the first EC-approved anti-VEGF treatment to demonstrate superior resolution of retinal fluid, compared to Bayer’s Eylea. Read More